The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of “Reduce” from Analysts

The Beauty Health Company (NASDAQ:SKIN) has received a consensus recommendation of “Reduce” from the eleven brokerages that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and one has issued a buy recommendation on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $2.46.

A number of analysts recently weighed in on the stock. Canaccord Genuity Group lowered their target price on shares of Beauty Health from $2.00 to $1.25 and set a “hold” rating on the stock in a research note on Monday, August 12th. Piper Sandler reiterated an “underweight” rating and issued a $1.00 price objective (down from $1.50) on shares of Beauty Health in a research note on Friday, August 9th. Finally, Stifel Nicolaus cut their target price on Beauty Health from $4.00 to $2.00 and set a “hold” rating for the company in a research report on Friday, July 26th.

Beauty Health Price Performance

Shares of NASDAQ:SKIN opened at $1.56 on Friday. The firm has a market capitalization of $193.47 million, a PE ratio of -1.88 and a beta of 0.94. The company has a current ratio of 6.49, a quick ratio of 5.47 and a debt-to-equity ratio of 7.96. Beauty Health has a 1-year low of $0.91 and a 1-year high of $5.71. The business’s 50 day moving average is $1.50 and its 200-day moving average is $2.22.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). The business had revenue of $90.60 million for the quarter, compared to analyst estimates of $98.46 million. Beauty Health had a negative return on equity of 4.57% and a negative net margin of 22.86%. Sell-side analysts predict that Beauty Health will post -0.2 earnings per share for the current year.

Insider Buying and Selling

In other Beauty Health news, Chairman Brent L. Saunders acquired 40,450 shares of the business’s stock in a transaction on Monday, August 12th. The stock was purchased at an average price of $1.08 per share, for a total transaction of $43,686.00. Following the transaction, the chairman now owns 5,921,769 shares in the company, valued at $6,395,510.52. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 41.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Beauty Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SKIN. Jacobs Levy Equity Management Inc. bought a new stake in shares of Beauty Health during the first quarter valued at approximately $4,297,000. Federated Hermes Inc. boosted its position in Beauty Health by 349,616.0% in the 2nd quarter. Federated Hermes Inc. now owns 370,699 shares of the company’s stock valued at $712,000 after buying an additional 370,593 shares during the last quarter. Bayesian Capital Management LP acquired a new stake in shares of Beauty Health in the 1st quarter valued at $521,000. Bank of New York Mellon Corp raised its position in shares of Beauty Health by 24.9% during the second quarter. Bank of New York Mellon Corp now owns 348,108 shares of the company’s stock worth $668,000 after acquiring an additional 69,329 shares during the last quarter. Finally, Russell Investments Group Ltd. acquired a new position in shares of Beauty Health during the first quarter valued at $279,000. Institutional investors and hedge funds own 93.26% of the company’s stock.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.